ELK1 and central nervous system cancer: These results suggest that enriched ETS regulons have both unique and common gene targets in gliomas, as indicated by a clear separation of negatively and positively correlated targets in regulons such as ETS2 and ELK1 (unique), and overlapping negative and positive regulons, such as those of ELF4 and ELK3 (common).